2m 2m 2m 2m 2m 2m 2m
Curaleaf Hldg-SV (CURLF)
OTC
$3.59-$0.05 (-1.37%)
Price as of Jun 02, 2026- $2.4BMarket Cap
- 337.80%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Curaleaf Hldg-SV (CURLF)
$3.59-$0.05 (-1.37%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.3B -6.55% | 1.3B -0.28% | 1.3B +0.77% | 1.3B +11.74% | |
Cost of Revenue | 637.1M -9.44% | 703.6M -3.91% | 732.2M -3.32% | 757.3M N/A | |
Gross Profit | 631.0M -1.29% | 639.2M +4.04% | 614.4M +6.12% | 579.0M -14.59% | |
Sales and Marketing Expense | 428.4M +1.64% | 421.5M +1.63% | 414.8M -7.32% | 447.5M +20.92% | |
Research and Development Expense | -805,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 196.6M -15.70% | 233.2M +19.07% | 195.9M +19.61% | 163.8M +23.47% | |
Total Operating Expenses | 605.6M -2.18% | 619.1M +8.31% | 571.6M -3.35% | 591.4M +59.79% | |
Operating Profit | 25.4M +26.01% | 20.2M -52.90% | 42.9M +446.61% | -12.4M -107.45% | |
Interest Income | 663,000 -14.56% | 776,000 +3,273.91% | 23,000 -83.21% | 137,000 N/A | |
Interest Expense | -56.8M -4.38% | -59.4M +2.39% | -58.0M -2.57% | -59.5M N/A | |
Interest Income and Expense and Net | -56.1M -4.25% | -58.6M +1.09% | -57.9M -2.39% | -59.4M N/A | |
Total Nonoperating Income and Expense | -103.7M -24.79% | -137.8M -17.59% | -167.2M -21.87% | -214.1M N/A | |
Income before Taxes | -78.2M -33.51% | -117.6M -5.42% | -124.4M -45.08% | -226.4M +90.64% | |
Income Taxes | 123.7M +25.46% | 98.6M -13.96% | 114.6M -23.86% | 150.5M -13.47% | |
Extraordinary Items | 9.1M -83.26% | 54.2M N/A | N/A N/A | N/A N/A | |
Net Income | -231.1M +7.26% | -215.4M -23.39% | -281.2M -24.02% | -370.1M +211.60% | |
Net Income from Continuing Operations Applicable to Common | -78.2M -33.51% | -117.6M -5.42% | -124.4M -45.08% | -226.4M +90.64% | |
Basic EPS and Net Income | -0.35 +9.38% | -0.32 -17.95% | -0.39 -25.00% | -0.52 +225.00% | |
Diluted EPS and Net Income | -0.35 +9.38% | -0.32 -17.95% | -0.39 -25.00% | -0.52 +225.00% | |
Basic Weighted Average Shares | 762.1M +2.87% | 740.8M +2.31% | 724.1M +1.82% | 711.2M +1.77% | |
Diluted Weighted Average Shares | 762.1M +2.87% | 740.8M +2.31% | 724.1M +1.82% | 711.2M +1.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 101.6M -5.27% | 107.2M +16.78% | 91.8M -43.73% | 163.2M -45.49% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 101.6M -5.27% | 107.2M +16.78% | 91.8M -43.73% | 163.2M -45.49% | |
Total Current Assets | 448.6M +4.41% | 429.7M +2.65% | 418.6M -30.85% | 605.3M -35.78% | |
Accumulated Depreciation | 333.6M +26.80% | 263.1M +43.12% | 183.8M +42.81% | 128.7M N/A | |
Property and Plant and Equipment and Net | 520.4M -4.77% | 546.4M -4.41% | 571.6M -7.53% | 618.2M +62.79% | |
Total Long-Term Assets | 520.4M -4.77% | 546.4M +4,246.72% | 12.6M -73.93% | 48.2M -84.11% | |
Total Assets | 2.8B -3.53% | 2.9B -4.75% | 3.1B -8.87% | 3.4B +4.46% | |
Income Taxes Payable | 231.0M -13.83% | 268.0M -45.88% | 495.2M +11.24% | 445.2M N/A | |
Total Short-Term Debt | 35.7M -64.88% | 101.7M +157.67% | 39.5M -24.03% | 52.0M N/A | |
Total Current Liabilities | 294.3M -24.13% | 387.9M -21.48% | 494.0M +0.60% | 491.1M +55.70% | |
Total Long-Term Debt | 512.9M +9.86% | 466.9M -14.84% | 548.3M -3.95% | 570.9M N/A | |
Total Long-Term Liabilities | 1.2M +9.18% | 1.1M -15.82% | 1.3M -98.58% | 94.8M +25.09% | |
Total Liabilities | 2.0B +2.50% | 2.0B +1.60% | 1.9B -3.60% | 2.0B +37.35% | |
Retained Earnings | -1.6B +17.04% | -1.4B +18.88% | -1.1B +32.71% | -859.6M +185.53% | |
Total Stockholders Equity | 756.4M -12.18% | 861.2M -18.03% | 1.1B -17.90% | 1.3B -28.86% | |
Total Shares Outstanding | 678.5M -9.54% | 750.1M +2.23% | 733.7M +680.80% | 94.0M -93.37% | |
Cash Flow | |||||
Cash from Operating Activities | 137.7M -15.29% | 162.6M +116.01% | 75.3M +62.20% | 46.4M +236.62% | |
Capital Expenditures | 63.4M -31.90% | 93.2M +42.34% | 65.4M -52.70% | 138.4M N/A | |
Cash from Investing Activities | -70.3M -25.03% | -93.8M +19.24% | -78.7M -65.58% | -228.6M +39.43% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -73.5M +35.50% | -54.2M -19.07% | -67.0M -232.60% | 50.5M -88.10% | |
Financials Ratio | |||||
Gross Margin | 49.23% +3.41% | 47.61% +4.33% | 45.63% +5.31% | 43.33% N/A | |
Operating Margin | 2.03% +34.84% | 1.50% -52.77% | 3.18% +443.97% | -0.93% -106.67% | |
Return on Assets | -7.97% +11.91% | -7.13% -17.71% | -8.66% -22.19% | -11.13% +164.22% | |
Return on Equity | -28.57% +26.78% | -22.54% -6.62% | -24.13% +0.37% | -24.04% +221.37% | |
Revenue Growth | -6.55% +2,203.80% | -0.28% -136.94% | 0.77% -93.44% | 11.74% -87.08% | |
Current Ratio | 1.52 +37.62% | 1.11 +30.72% | 0.85 -31.26% | 1.23 -58.75% | |
Cash Ratio | 0.35 +24.86% | 0.28 +48.68% | 0.19 -44.06% | 0.33 -64.99% | |
Debt-to-Equity Ratio | 0.73 +9.86% | 0.66 +18.04% | 0.56 +14.94% | 0.49 N/A | |
Debt-to-Assets Ratio | 0.19 0.00% | 0.19 +1.58% | 0.19 +3.55% | 0.18 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow